Bendamustine Hydrochloride

CAS 3543-75-7 11 FDA-DMF suppliersSmall Molecule

Overview

Bendamustine Hydrochloride is a bifunctional alkylating agent used for the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin's lymphoma (NHL). It interferes with the growth of cancer cells by causing DNA cross-linking, leading to cell death.

API suppliers (4)

Suppliers of Bendamustine Hydrochloride backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • CHEMPACIFIC CORPUnited States1 active DMF
  • CHEMPACIFIC CORPUnited States1 active DMF
  • FRESENIUS KABI ONCOLOGY LTD
  • ITF CHEMICAL LTDABrazil

Therapeutic areas

Oncology

Related APIs

Paclitaxel
33 suppliers
Anastrozole
28 suppliers
Capecitabine
27 suppliers
Bicalutamide
26 suppliers
Zoledronic Acid
25 suppliers
Dasatinib
24 suppliers
Bortezomib
24 suppliers
Deferasirox
24 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo